How can EMA/FDA alignment speed vaccine and rare-trial approvals?
A researcher recalls a family shuttling between Brussels and Boston for a vaccine trial. Harmonizing EMA and FDA guidance frameworks can cut months and costs, streamline data work for clinical data managers, and speed approvals for vaccines and rare trials.
Robert Maxwell
Sep 26, 2025
breast cancer trials
Vaccine EUA pathways
Parkinson disease trials
Stroke regulatory compliance
